A joint physics and radiobiology DREAM team vision - Towards better response prediction models to advance radiotherapy

Radiotherapy developed empirically through experience balancing tumour control and normal tissue toxicities. Early simple mathematical models formalized this practical knowledge and enabled effective cancer treatment to date. Remarkable advances in technology, computing, and experimental biology now create opportunities to incorporate this knowledge into enhanced computational models. The ESTRO DREAM (Dose Response, Experiment, Analysis, Modelling) workshop brought together experts across disciplines to pursue the vision of personalized radiotherapy for optimal outcomes through advanced modelling. The ultimate vision is leveraging quantitative models dynamically during therapy to ultimately achieve truly adaptive and biologically guided radiotherapy at the population as well as individual patient-based levels. This requires the generation of models that inform response-based adaptations, individually optimized delivery and enable biological monitoring to provide decision support to clinicians. The goal is expanding to models that can drive the realization of personalized therapy for optimal outcomes. This position paper provides their propositions that describe how innovations in biology, physics, mathematics, and data science including AI could inform models and improve predictions. It consolidates the DREAM team's consensus on scientific priorities and organizational requirements. Scientifically, it stresses the need for rigorous, multifaceted model development, comprehensive validation and clinical applicability and significance. Organizationally, it reinforces the prerequisites of interdisciplinary research and collaboration between physicians, medical physicists, radiobiologists, and computational scientists throughout model development. Solely by a shared understanding of clinical needs, biological mechanisms, and computational methods, more informed models can be created. Future research environment and support must facilitate this integrative method of operation across multiple disciplines.

Traumatic fracture of the medial coronoid process in a dog

This case report describes an acute traumatic fracture of the medial coronoid process (MCP) in an immature male Rottweiler. On routine radiographs of the left elbow joint, clear abnormalities could not be detected. The definitive diagnosis was based on craniolaterocaudomedial oblique radiographs and a CT scan. The fragment was removed arthroscopically via a medial approach. Histologically the fragment did not show any signs of degeneration nor demineralisation, as seen in classical fragments of the medial coronoid process. One week after treatment, complete limb function had been regained. Follow-up radiographs after nine month showed a minimal increase of osteoarthrosis.

Molecular and Immunohistochemical Distinction of Equine Sarcoid From Schwannoma

Ten equine skin tumors that had been classified as schwannomas on routine histological examination were analyzed by polymerase chain reaction for bovine papillomavirus DNA. All 10 were positive for bovine papillomavirus 1 or 2, and all 10 were immunohistochemically negative for S-100 protein and strongly positive for vimentin. Nine tumors were moderately positive for laminin and 8, for smooth muscle actin. Five tumors were variably and weakly positive for type IV collagen. The lack of S-100 protein expression made Schwann cells an unlikely cell of origin, as opposed to peripheral nerve sheath tumors, which typically express S-100 protein, at least in some neoplastic cells. The immunohistochemical reactivity is consistent with myofibroblastic origin of the neoplastic cells, although smooth muscle cell or pericyte origin cannot be ruled out. These tumors represent an atypical form of equine sarcoid. Polymerase chain reaction for bovine papillomavirus and S-100 immunohistochemistry are strongly recommended for all equine skin tumors with histological characteristics typical of schwannoma or peripheral nerve sheath tumor.

Pathogenic interactions between Chlamydophila psittaci and avian pneumovirus infections in turkeys

Both Chlamydophila psittaci and avian pneumovirus (APV) are highly prevalent in Belgian turkeys and might contribute to the respiratory disease complex observed in turkeys. Initial outbreaks of chlamydiosis occur mostly at the age of 4-8 weeks, often accompanied by an APV infection in APV non-vaccinated farms. Regardless APV vaccination, breakthroughs of APV infection from 8 weeks on do occur, a period when also a second C. psittaci infection appears. Therefore, this study examined the pathogenicity of an APV superinfection in C. psittaci predisposed turkeys. Turkeys were infected with C. psittaci, APV or with C. psittaci followed by APV. Simulating the impact of an APV infection during the acute phase or latent phase of a C. psittaci infection, turkeys have been infected with APV at 1 and 5 weeks post C. psittaci infection, respectively. APV infection during the acute phase of a C. psittaci infection aggravates the severity of clinical signs, macroscopic lesions, pharyngeal APV excretion and histological tracheae lesions. In contrast, no clear interaction could be established after APV infection in latently C. psittaci infected specific pathogen-free (SPF) turkeys. This study clearly demonstrates the exacerbating role of APV during acute C. psittaci infection, which can play an important role in the respiratory disease complex of turkeys.

A comparison of norepinephrine- and ACTH-stimulated lipolysis in white and brown adipocytes of female rats

1. Isolated white and brown adipocytes (WFA and BFA) from the rat were compared with respect to their lipolytic responsiveness towards norepinephrine (NE) and adrenocorticotrophic hormone (ACTH). 2. NE yielded a Km value of 702.7 +/- 30.6 nM for WFA and 142.5 +/- 7.2 nM for BFA. The maximum lipolytic response (Vm) was 145.7 +/- 1.2 nmol glycerol/micrograms DNA/90 min for WFA and 23.7 +/- 0.2 nmol glycerol/micrograms DNA/90 min for BFA. 3. ACTH yield Km values of 31.6 +/- 1.5 and 31.9 +/- 3.1 nM for WFA and BFA, respectively. Vm values of 141.9 +/- 1.0 and 34.2 +/- 0.5 nmol glycerol/micrograms DNA/90 min were observed for WFA and BFA, respectively.